$AYTU
AYTU BIOPHARMA, INC Stock $aytu

$aytu Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000114420417026452 Filed on May 11, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$840.0K	$893.5K	$668.5K
YoY Change	-10.64%	33.66%	2705.58%
Cost Of Revenue	$350.0K	$324.4K	$340.8K
YoY Change	6.06%	-4.8%
Gross Profit	$490.0K	$569.1K	$327.7K
YoY Change	-18.33%	73.64%	1275.4%
Gross Profit Margin	58.33%	63.69%	49.02%
Selling, General & Admin	$3.740M	$4.385M	$2.165M
YoY Change	18.73%	102.53%	102.33%
% of Gross Profit	763.27%	770.53%	660.62%
Research & Development	$190.0K	$279.0K	$1.144M
YoY Change	-93.38%	-75.6%	64.75%
% of Gross Profit	38.78%	49.03%	348.95%
Depreciation & Amortization	$2.100M	$27.00K	$18.00K
YoY Change	377.27%	50.0%
% of Gross Profit	428.57%	4.74%	5.49%
Operating Expenses	$4.320M	$5.753M	$3.896M
YoY Change	-32.61%	47.68%	112.9%
Operating Profit	-$3.830M	-$4.860M	-$3.227M
YoY Change	-34.08%	50.58%	78.69%
Interest Expense	-$1.650M	$80.72K	$4.075M
YoY Change	-17.5%	-98.02%	11202.2%
% of Operating Profit
Other Income/Expense, Net		-$356.5K	-$4.047M
YoY Change		-91.19%	11124.58%
Pretax Income	-$6.750M	-$5.220M	-$7.274M
YoY Change	-55.88%	-28.24%	294.86%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$6.750M	-$5.216M	-$7.274M
YoY Change	-55.88%	-28.29%	294.86%
Net Earnings / Revenue	-803.57%	-583.78%	-1088.05%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.850B	-$1.908B	-$18.54B
COMMON SHARES
Basic Shares Outstanding	13.84M shares	10.85M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$800.0K	$3.500M	$8.700M
YoY Change	-91.21%	-59.77%
Cash & Equivalents	$802.3K	$3.470M	$8.666M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$400.0K	$400.0K	$1.100M
YoY Change	33.33%	-63.64%
Inventory	$1.312M	$200.0K	$621.4K
Prepaid Expenses			$943.1K
Receivables	$528.0K	$300.0K	$84.27K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.029M	$4.400M	$10.44M
YoY Change	-70.07%	-57.84%	532.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$647.3K	$300.0K	$196.9K
YoY Change	179.68%	52.37%	438.07%
Goodwill	$238.4K		$221.0K
YoY Change	7.89%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$9.231M	$9.561M	$200.0K
YoY Change	-12.5%	4680.38%
Total Long-Term Assets	$11.97M	$11.48M	$11.55M
YoY Change	-15.84%	-0.61%	35.06%
TOTAL ASSETS
Total Short-Term Assets	$3.029M	$4.400M	$10.44M
Total Long-Term Assets	$11.97M	$11.48M	$11.55M
Total Assets	$15.00M	$15.90M	$21.99M
YoY Change	-38.38%	-27.68%	115.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.220M	$1.409M	$1.200M
YoY Change	-4.4%	17.41%	119.64%
Accrued Expenses	$782.5K	$1.051M	$800.0K
YoY Change	-34.63%	31.35%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.610M	$3.354M	$3.205M
YoY Change	-64.27%	4.65%	-65.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.400M	$4.000M	$1.200M
YoY Change	76.19%	233.33%	200.0%
Total Long-Term Liabilities	$7.400M	$4.000M	$1.200M
YoY Change	76.19%	233.33%	200.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.610M	$3.354M	$3.205M
Total Long-Term Liabilities	$7.400M	$4.000M	$1.200M
Total Liabilities	$11.00M	$7.395M	$4.420M
YoY Change	-22.86%	67.32%	-54.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$69.07M	-$62.32M	-$31.26M
YoY Change	48.34%	99.33%	147.93%
Common Stock	$73.07M	$70.84M	$48.83M
YoY Change	28.99%	45.08%	271.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.000M	$8.521M	$17.57M
YoY Change
Total Liabilities & Shareholders Equity	$15.00M	$15.92M	$21.99M
YoY Change	-38.39%	-27.6%	115.51%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$6.750M	-$5.216M	-$7.274M
YoY Change	-55.88%	-28.29%	294.86%
Depreciation, Depletion And Amortization	$2.100M	$27.00K	$18.00K
YoY Change	377.27%	50.0%
Cash From Operating Activities	-$3.270M	-$2.390M	-$2.380M
YoY Change	22.47%	0.42%	23700.0%
INVESTING ACTIVITIES
Capital Expenditures	-$60.00K	$1.990M	-$70.00K
YoY Change	-94.5%	-2942.86%
Acquisitions
YoY Change
Other Investing Activities	$600.0K	-$3.270M	$0.00
YoY Change	-117.29%
Cash From Investing Activities	$540.0K	-$1.280M	-$80.00K
YoY Change	-111.84%	1500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	60.00K	1.920M	170.0K
YoY Change	-99.09%	1029.41%
NET CHANGE
Cash From Operating Activities	-3.270M	-2.390M	-2.380M
Cash From Investing Activities	540.0K	-1.280M	-80.00K
Cash From Financing Activities	60.00K	1.920M	170.0K
Net Change In Cash	-2.670M	-1.750M	-2.290M
YoY Change	330.65%	-23.58%	22800.0%
FREE CASH FLOW
Cash From Operating Activities	-$3.270M	-$2.390M	-$2.380M
Capital Expenditures	-$60.00K	$1.990M	-$70.00K
Free Cash Flow	-$3.210M	-$4.380M	-$2.310M
YoY Change	103.16%	89.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	35767	USD
CY2016Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	79612	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	118697	USD
CY2016Q2	us-gaap	Accrued Rent Current AccruedRentCurrent	4109	USD
CY2017Q1	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	75107	USD
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10938603	shares
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1408953	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2322605	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2017Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	11478404	USD
CY2016Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	14222780	USD
CY2017Q1	us-gaap	Licenses Revenue LicensesRevenue	0	USD
CY2016Q1	us-gaap	Licenses Revenue LicensesRevenue	21429	USD
CY2017Q1	us-gaap	Revenues Revenues	893548	USD
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	324438	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	279049	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.64
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4046685	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-356515	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	4074668	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	80722	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46561425	USD
CY2016Q2	us-gaap	Liabilities Liabilities	14257754	USD
CY2017Q1	aytu	Accrued Compensation Current AccruedCompensationCurrent	845571	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10104425	USD
CY2016Q2	aytu	Accrued Compensation Current AccruedCompensationCurrent	1200930	USD
CY2016Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	275992	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3354437	USD
CY2017Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3119	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2017Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	42667	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2017Q1	us-gaap	Liabilities Liabilities	7395220	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8215	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8054190	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3470158	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	70839253	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	56646304	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62319341	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	10085253	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15916516	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	1384	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	374	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9560754	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10549797	USD
CY2017Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	0	USD
CY2016Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	5379675	USD
CY2017Q1	us-gaap	Accrued Rent Current AccruedRentCurrent	6430	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	8521296	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24343007	USD
CY2016Q1	us-gaap	Revenues Revenues	668541	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	340796	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1143676	USD
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1569078	shares
CY2016Q2	us-gaap	Short Term Investments ShortTermInvestments	1041362	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-7274058	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15757916	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4073592	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3227373	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4859827	USD
	us-gaap	Interest Expense InterestExpense	4428136	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	212809	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-50054	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-732897	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4478190	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7562342	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1314308	shares
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.08
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-9.80
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-5216342	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12882626	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	655416	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	596434	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2165135	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4385145	USD
CY2016Q1	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	47998	USD
CY2017Q1	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	291963	USD
CY2017Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	16662	USD
CY2016Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	27983	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	5753375	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	3895914	USD
	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Licenses Revenue LicensesRevenue	64286	USD
	us-gaap	Revenues Revenues	2385701	USD
	us-gaap	Revenues Revenues	1625140	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1067654	USD
	us-gaap	Cost Of Revenue CostOfRevenue	622222	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	774526	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3308009	USD
	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	387960	USD
	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	143994	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13732226	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5416038	USD
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	137311	USD
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	254680	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	437013	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1311043	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	284633	USD
	us-gaap	Operating Expenses OperatingExpenses	17410720	USD
	us-gaap	Operating Expenses OperatingExpenses	10029576	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15025019	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8404436	USD
	us-gaap	Interest Expense InterestExpense	884187	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	607234	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	509996	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2241989	USD
	aytu	Adjustments To Additional Paid In Capital Warrants Issued In Connection With Equity Financing AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConnectionWithEquityFinancing	3470646	USD
	aytu	Adjustments To Additional Paid In Capital Warrants Issued In Connection With Equity Financing To Placement Agents For Over Allotment Option AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConnectionWithEquityFinancingToPlacementAgentsForOverAllotmentOption	172629	USD
	aytu	Stock And Issued During Period Value StockAndIssuedDuringPeriodValue	3671581	USD
	aytu	Adjustments To Additional Paid In Capital Warrants Issued In Connection With Equity Financing To Placement Agents Noncash Issuance Costs AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConnectionWithEquityFinancingToPlacementAgentsNoncashIssuanceCosts	292630	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10560768	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10125435	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4508925	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2263975	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	750000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53435	USD
CY2016	aytu	Class Of Warrant Or Rights Weighted Average Remaining Contractual Term ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm	P4Y8M16D
	aytu	Class Of Warrant Or Rights Weighted Average Remaining Contractual Term ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm	P4Y5M23D
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	24247	USD
	aytu	Issuance Of Common Stock To Executives IssuanceOfCommonStockToExecutives	509996	USD
	aytu	Issuance Of Common Stock To Executives IssuanceOfCommonStockToExecutives	0	USD
	aytu	Fixed Assets Included In Accounts Payable FixedAssetsIncludedInAccountsPayable	0	USD
	aytu	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	8602500	USD
	aytu	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2852	USD
	aytu	Warrants Issued In Connection With Equity Financing To Placement Agents WarrantsIssuedInConnectionWithEquityFinancingToPlacementAgents	292630	USD
	aytu	Warrants Issued In Connection With Equity Financing To Placement Agents WarrantsIssuedInConnectionWithEquityFinancingToPlacementAgents	0	USD
CY2017Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	184000	USD
	aytu	Payments For Registered Offering Costs PaymentsForRegisteredOfferingCosts	0	USD
	aytu	Warrant Derivative Liability Related To Issuance Of Convertible Promissory Notes WarrantDerivativeLiabilityRelatedToIssuanceOfConvertiblePromissoryNotes	0	USD
	aytu	Primsol Business Purchase Included In Primsol Payable PrimsolBusinessPurchaseIncludedInPrimsolPayable	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	596434	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	631481	USD
	aytu	Fixed Assets Included In Accounts Payable FixedAssetsIncludedInAccountsPayable	58683	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2241989	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	655416	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	547109	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	433471	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	178338	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7992571	USD
	aytu	Payments For Deposits Investing Activities PaymentsForDepositsInvestingActivities	0	USD
	aytu	Payments For Deposits Investing Activities PaymentsForDepositsInvestingActivities	-1998	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	203577	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	540000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-741579	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5175000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	298322	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10046924	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1312774	USD
	aytu	Warrant Derivative Liability Related To Issuance Of Convertible Promissory Notes WarrantDerivativeLiabilityRelatedToIssuanceOfConvertiblePromissoryNotes	102931	USD
	aytu	Primsol Business Purchase Included In Primsol Payable PrimsolBusinessPurchaseIncludedInPrimsolPayable	1077000	USD
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	5000000	USD
	aytu	Payments For Registered Offering Costs PaymentsForRegisteredOfferingCosts	997865	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	112000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	894000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	647000	USD
CY2017Q1	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	0	USD
CY2016Q1	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	21000	USD
CY2016Q2	us-gaap	Deferred Revenue DeferredRevenue	426000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	2386000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1561000	USD
	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	0	USD
	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	64000	USD
CY2017Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1041000	USD
CY2017Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	35000	USD
CY2016Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	35000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	105000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	86000	USD
CY2015Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5200000	USD
CY2015Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	401000	USD
CY2015Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	103000	USD
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	318000	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	322302	shares
CY2015Q3	aytu	Placement Agents Cash Fee Percentage PlacementAgentsCashFeePercentage	0.08	pure
	aytu	Placement Agents Cash Fee Percentage PlacementAgentsCashFeePercentage	0.08	pure
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	20000	USD
CY2016Q1	aytu	Warrants Issued To Purchase Of Common Stock WarrantsIssuedToPurchaseOfCommonStock	22254	shares
CY2016Q1	aytu	Warrants Exercise Price Per Share WarrantsExercisePricePerShare	7.80
CY2016Q2	aytu	Warrants Issued To Purchase Of Common Stock WarrantsIssuedToPurchaseOfCommonStock	22564	shares
CY2016Q2	aytu	Warrants Exercise Price Per Share WarrantsExercisePricePerShare	4.80
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13836607	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3741944	shares
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	173000	USD
CY2016Q4	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	441999	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	371636	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.93
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.82
CY2017Q1	aytu	Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant	1263034	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	736966	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.82
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y14D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M29D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M11D
	aytu	Unrecognized Share Based Compensation Expenses UnrecognizedShareBasedCompensationExpenses	1022000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y22D
CY2016Q2	aytu	Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice	6.19
CY2017Q1	aytu	Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice	2.51
CY2016Q2	aytu	Share Based Compensation Share Warrants Outstanding ShareBasedCompensationShareWarrantsOutstanding	2201627	shares
CY2017Q1	aytu	Share Based Compensation Share Warrants Outstanding ShareBasedCompensationShareWarrantsOutstanding	5720313	shares
	aytu	Share Based Compensation Share Warrants Issued As Part Of Settlement ShareBasedCompensationShareWarrantsIssuedAsPartOfSettlement	88032	shares
	aytu	Share Based Compensation Share Warrants Issued As Part Of Settlement Weighted Average Exercise Price ShareBasedCompensationShareWarrantsIssuedAsPartOfSettlementWeightedAverageExercisePrice	4
	aytu	Share Based Compensation Share Warrants Issued On Registered Offering ShareBasedCompensationShareWarrantsIssuedOnRegisteredOffering	6020245	shares
	aytu	Share Based Compensation Share Warrants Issued On Placement Agents For Registered Offering ShareBasedCompensationShareWarrantsIssuedOnPlacementAgentsForRegisteredOffering	401450	shares
	aytu	Share Based Compensation Share Warrants Issued On Registered Offeringweighted Average Exercise Price ShareBasedCompensationShareWarrantsIssuedOnRegisteredOfferingweightedAverageExercisePrice	1.86
	aytu	Share Based Compensation Share Warrants Issued On Placement Agents For Registered Offeringweighted Average Exercise Price ShareBasedCompensationShareWarrantsIssuedOnPlacementAgentsForRegisteredOfferingweightedAverageExercisePrice	0.75
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	AYTU BIOSCIENCE, INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001385818
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	AYTU
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13836607	shares
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1050816	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1197106	USD
CY2017Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4037664	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3869122	USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13836607	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3741944	shares
CY2017Q1	aytu	Products And Services Revenue ProductsAndServicesRevenue	893548	USD
CY2016Q1	aytu	Products And Services Revenue ProductsAndServicesRevenue	647112	USD
	aytu	Products And Services Revenue ProductsAndServicesRevenue	2385701	USD
	aytu	Products And Services Revenue ProductsAndServicesRevenue	1560854	USD
CY2017Q1	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	0	USD
CY2016Q1	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	0	USD
	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	230936	USD
	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	292455	USD
CY2016Q1	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	292455	USD
	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	581910	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	126555	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25980	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1355	shares
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1910714	USD
	aytu	Adjustments To Additional Paid In Capital Warrant Amendments AdjustmentsToAdditionalPaidInCapitalWarrantAmendments	64690	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.23
	aytu	Share Based Compensation Share Warrants Excercised ShareBasedCompensationShareWarrantsExcercised	2991041	shares
	aytu	Share Based Compensation Share Warrants Excercised Weighted Average Exercise Price ShareBasedCompensationShareWarrantsExcercisedWeightedAverageExercisePrice	0.75
	us-gaap	Availableforsale Securities Gross Unrealized Gain Loss1 AvailableforsaleSecuritiesGrossUnrealizedGainLoss1	-61519	USD
	us-gaap	Availableforsale Securities Gross Unrealized Gain Loss1 AvailableforsaleSecuritiesGrossUnrealizedGainLoss1	0	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	428374	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	1507	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	aytu	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	0	USD
	aytu	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	3942613	USD
	aytu	Amortization Of Prepaid Research And Development Due To Related Parties AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties	335454	USD
	aytu	Amortization Of Prepaid Research And Development Due To Related Parties AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties	91487	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	180110	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-72784	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-290984	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	572238	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-307854	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	50053	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-146290	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-68372	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-10560	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-64286	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	6000000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	1071707	USD
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	91864	USD
	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	1750000	USD
	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	0	USD
	aytu	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	-355359	USD
	aytu	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	591451	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	208941	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	2775	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	200000	USD
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	29754	USD
	aytu	Payments For Warrant Tender Offer Cost PaymentsForWarrantTenderOfferCost	332567	USD
	aytu	Payments For Warrant Tender Offer Cost PaymentsForWarrantTenderOfferCost	0	USD
	aytu	Proceeds From Issuance Of Warrant Tender Offer ProceedsFromIssuanceOfWarrantTenderOffer	2243281	USD
	aytu	Proceeds From Issuance Of Warrant Tender Offer ProceedsFromIssuanceOfWarrantTenderOffer	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4268000	USD
	aytu	Adjustment To Additional Capital Issuance Of Warrants Related To Convertible Promissory Note AdjustmentToAdditionalCapitalIssuanceOfWarrantsRelatedToConvertiblePromissoryNote	0	USD
	aytu	Adjustment To Additional Capital Issuance Of Warrants Related To Convertible Promissory Note AdjustmentToAdditionalCapitalIssuanceOfWarrantsRelatedToConvertiblePromissoryNote	87000	USD
	aytu	Debt Instrument Convertible Beneficial Conversion Feature Net Of Accretion DebtInstrumentConvertibleBeneficialConversionFeatureNetOfAccretion	0	USD
	aytu	Debt Instrument Convertible Beneficial Conversion Feature Net Of Accretion DebtInstrumentConvertibleBeneficialConversionFeatureNetOfAccretion	1001000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	183000	USD
	aytu	Warrants Amended In Connection With Warrant Tender Offer WarrantsAmendedInConnectionWithWarrantTenderOffer	63183	USD
	aytu	Warrants Amended In Connection With Warrant Tender Offer WarrantsAmendedInConnectionWithWarrantTenderOffer	0	USD
	aytu	Primsol Business Purchase Included In Primsol Payable Gross PrimsolBusinessPurchaseIncludedInPrimsolPayableGross	1250000	USD
	aytu	Primsol Business Purchase Included In Primsol Payable Gross PrimsolBusinessPurchaseIncludedInPrimsolPayableGross	1250000	USD
	us-gaap	Standardized Measure Of Discounted Future Net Cash Flow Relating To Proved Oil And Gas Reserves Accretion Of Discount StandardizedMeasureOfDiscountedFutureNetCashFlowRelatingToProvedOilAndGasReservesAccretionOfDiscount	173000	USD
	us-gaap	Standardized Measure Of Discounted Future Net Cash Flow Relating To Proved Oil And Gas Reserves Accretion Of Discount StandardizedMeasureOfDiscountedFutureNetCashFlowRelatingToProvedOilAndGasReservesAccretionOfDiscount	173000	USD
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	143000	USD
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	143000	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	4943073	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	4943073	USD
	us-gaap	Accretion Expense AccretionExpense	3942613	USD
	us-gaap	Accretion Expense AccretionExpense	3942613	USD
CY2017Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
CY2017Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2991041	shares
CY2017Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2200000	USD
CY2017Q1	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	513000	USD
CY2017Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	743000	USD
CY2017Q1	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	603000	USD
CY2017Q1	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	2500000	USD
CY2017Q1	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	0	USD
CY2017Q1	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	0	USD
CY2017Q1	us-gaap	Contractual Obligation ContractualObligation	4359000	USD
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On June 8, 2015, we reincorporated as a domestic Delaware corporation under Delaware General Corporate Law and changed our name from Rosewind Corporation to Aytu BioScience, Inc., and effected a reverse stock split in which each common stockholder received one share of common stock for every 12.174 shares outstanding. On June 30, 2016, Aytu effected another reverse stock split in which each common stockholder received one share of common stock for every 12 shares outstanding (herein referred to collectively as the Reverse Stock Splits). All share and per share amounts in this report have been adjusted to reflect the effect of these Reverse Stock Splits.
CY2017Q1	us-gaap	Depreciation Depreciation	27000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	18000	USD
	us-gaap	Depreciation Depreciation	72000	USD
	us-gaap	Depreciation Depreciation	37000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	34000	USD
CY2017Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	510825	shares
CY2017Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	23000	USD
	aytu	Warrants Modified WarrantsModified	3510432	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.76
CY2017Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2991041	shares
CY2016Q3	aytu	Common Stock Option Repricing Program Description CommonStockOptionRepricingProgramDescription	Board of Directors approved a common stock option repricing program whereby previously granted and unexercised options held by our then current employees, consultants and directors with exercise prices above $6.00 per share were repriced on a one-for-one basis to $3.23 per share
	us-gaap	Debt Instrument Convertible Terms Of Conversion Feature DebtInstrumentConvertibleTermsOfConversionFeature	At the insistence of the underwriters of the offering, all outstanding noteholders had signed lockup agreements which granted them an extra 10% on the conversion, increasing it to 130% of shares calculated by dividing such Note balance by $4.80
CY2017Q1	aytu	Cash And Cash Equivalents And Restricted Cash Carrying Value CashAndCashEquivalentsAndRestrictedCashCarryingValue	3545265	USD
CY2016Q1	aytu	Cash And Cash Equivalents And Restricted Cash Carrying Value CashAndCashEquivalentsAndRestrictedCashCarryingValue	8665835	USD
CY2016Q2	aytu	Cash And Cash Equivalents And Restricted Cash Carrying Value CashAndCashEquivalentsAndRestrictedCashCarryingValue	8054190	USD
CY2015Q2	aytu	Cash And Cash Equivalents And Restricted Cash Carrying Value CashAndCashEquivalentsAndRestrictedCashCarryingValue	7353061	USD

Files In Submission

Name	View Source	Status
0001144204-17-026452-index-headers.html	Edgar Link	pending
0001144204-17-026452-index.html	Edgar Link	pending
0001144204-17-026452.txt	Edgar Link	pending
0001144204-17-026452-xbrl.zip	Edgar Link	pending
aytu-20170331.xml	Edgar Link	completed
aytu-20170331.xsd	Edgar Link	pending
aytu-20170331_cal.xml	Edgar Link	unprocessable
aytu-20170331_def.xml	Edgar Link	unprocessable
aytu-20170331_lab.xml	Edgar Link	unprocessable
aytu-20170331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v465720_10q.htm	Edgar Link	pending
v465720_ex10-1.htm	Edgar Link	pending
v465720_ex31-1.htm	Edgar Link	pending
v465720_ex31-2.htm	Edgar Link	pending
v465720_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AYTU
AYTU BIOPHARMA, INC Stock $aytu

2017 Q2 Form 10-Q Financial Statement

#000114420417026452 Filed on May 11, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU AYTU BIOPHARMA, INC Stock $aytu

2017 Q2 Form 10-Q Financial Statement

#000114420417026452 Filed on May 11, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU
AYTU BIOPHARMA, INC Stock $aytu